Today we are going to describe, in detail, an emerging crisis that has been dubbed one of the greatest threats to human existence.
With every crisis, however, opportunity is born…
Bee populations around the world are disappearing at an alarming rate. This is threatening a wide variety of food sources that simply cannot grow without bee pollination. It is a devastating trend that cannot be ignored as over 1/3 of all food is dependent upon pollination. As Greenpeace puts it, “you have a bee to thank for every one in three bites of food you eat.”
“If the bee disappeared off the face of the earth, man would only have four years left to live.”
– Maurice Maeterlinck, Nobel Prize recipient for literature in 1911.
In a 2014 article by Eco Watch, titled 10 Biggest Threats to Human Existence, a decline in global bee populations ranked as the #3 threat. Only climate change and a loss of biodiversity ranked higher.
Recent stats in respect to the loss of commercial bee populations is nothing short of alarming. Bees began dying at an accelerated and unsustainable rate in 2006…
Figure 1: Summary of the total colony losses over winter (October 1 – April 1) and over the year (April 1 – April 1) of managed honey bee colonies in the United States.
chart source: Beeinformed.org
Leading experts have concluded that an approximate 15% bee colony loss during the winter is acceptable, highlighted by the grey bar above. Total losses in the US, however, have exceeded 30% in 4 of the past 5 years.
How wide-reaching is this problem from an economic standpoint?
Bees touch over 70% of everything we eat and are used for pollination in 99% of greenhouses. Of the world’s 115 most important crops, 87 require pollination to produce fruits, nuts and seeds, accounting for roughly 1/3 of the $3 trillion agricultural produce sold each year.
According to the TEEB report (2010), the total economic value of insect pollination globally is estimated to be $170 billion, this equates to 9.5% of agricultural production. The global stock of domesticated honey bees is growing slower than agricultural demand for pollination. The estimated value of insect pollination for U.S. and European agriculture is $21 billion and $25 billion respectively.
For obvious economic reasons this threat isn’t just being reported by scientists, but by some of the largest financial outlets, including numerous pieces from Bloomberg. One of its articles, published in May, 2014, was titled Buzz Kill: U.S. Honeybees Aren’t Coming Back This Year. Another article from Bloombergin July, 2015 reported that “There’s a buzz about bees, and it’s bad. They’ve been dying at alarming rates for almost a decade, making it more expensive to produce the many crops that depend on them for pollination.”
Bees play a vital role for many of our crops.
In July, 2015 Business Insider published an article by Kerry Sheridan of the AFP, titled Bumblebees dying, losing ground to climate change, bringing this issue front and centre for many investors.
What could be contributing to the disappearance of bees?
According to Bees and Pesticides, “Neonicotinoids, especially seed treatments of imidacloprid and clothianidin on arable crops, have become of increasing concern to beekeepers and bee researchers in recent years with many of them suspecting that they may be connected to current bee declines.”
The neonicotinoid family includes imidacloprid, which is considered the most widely used insecticide in the world.
The Guardian reported in 2014 that a Harvard study showed “neonicotionoids are devastating bee colonies by triggerring colony collapse disorder.”
Reynard Loki, in his article titled Honeybees Face Global Threat: If They Die, So Do We, wrote that:
“The use of pesticides – neonicotinoids in particular, which are commonly used on corn, soybean, canola and cereal, as well as many fruits and vegetables – have killed an estimated 250 million bees in just a few years. Applied to plants, neonics travel through the plant’s vascular system and appear in roots, pollen and nectar that then are transferred to bees and their colonies…”
Dr. Reese Halter, a distinguished biologist, and award-winning broadcaster and writer spoke about the devastating global impact being witnessed:
“The bees are trying to tell us something very clearly. The way we are operating… isn’t working.”
“We’ve lost a quarter of a trillion honeybees, which have died prematurely in the last four years.”
Like most economic and environmental threats, solutions may be attained through innovation. To save the bees, it appears scientists must find a way to sustainably grow and control crop yields without the use of harmful pesticides. It’s just that simple.
One small-cap company based in Ontario, Canada, which only this July went public, has developed and owns patent-pending bee vectoring technology (consisting of a proprietary tray dispenser containing a unique carrier agent). This is designed to harmlessly utilize commercially reared bumblebees as natural delivery mechanisms, without water, for a variety of powdered mixtures comprised of organic compounds that inhibit or eliminate common crop diseases, while at the same time stimulating and enhancing the same crops. This unique and proprietary process facilitates a targeted delivery of crop controls using the simple process of bee pollination to replace traditional crop spraying, resulting in better yield, organic product and less impact on the environment without the use of water or disruptions to labour.
This company has a Board of Director member who, until recently, was a Global R&D Leader in crop protection for Syngenta (Swiss-based fertilizer company recently offered US$46.5 billion in an August takeover bid by Monsanto).
This innovative small-cap is Bee Vectoring Technologies International (BEE:TSXV)
(BEVVF:OTCQB), and it is aligning itself to help enable efficient and safe crop control.
In an article from TrendHunter, published earlier this year, Bee Vectoring Technologies is described as an:
“…innovative crop control company that’s on the verge of revolutionizing the agricultural industry.”
We spent months learning about Bee Vectoring Technologies before introducing it to you. If there is one industry in the world that needs to evolve, it’s agriculture. Many of its practices, as can be witnessed by the amount of pesticides used in large scale farming, may no longer be sustainable. Furthermore, with the world population expected to reach 11 billion by 2100 and well over 9 billion by 2050, this sector is poised to receive a flood of capital to ensure adequate food supply.
With increased soil degradation and growth in crop production slowing, according to the Food and Agriculture Organization of the United Nations, we can’t afford to risk degrading our land further with antiquated farming practices.
Bee Vectoring Technologies has a plan to control certain crop yields by using organic methods via its patent-pending product which distributes a natural compound to flowering crops, couriered by bumble bees in their natural daily routine.
Let’s break this down:
Bee Vectoring Technologies’ method is simple: the company has designed and is manufacturing the patent-pending VectorPak, a removable tray that fits inside bee hives. In the company’s own words, this is how the system works:
“BVT has developed an inoculum dispenser system that is incorporated into the lid of commercial bumble bee hives. In the dispenser is a removable tray that contains, in powder form, the inoculant crop control and a mixture of products (being, Vectorite) that allows the bees to effectively pick up the product on their way out of the hive.”
Remember, bees are used for pollination in approximately 99% of greenhouses. A BVT VectorPak is put at the lid of a commercial bumble bee hive. It channels the bees through it who then pick up the organic compound (inoculant) on their legs and bodies and then proceed to pollinate as they normally would, thereby spreading the biologic compound. The organic compound is resilient to disease and has been developed with the intent to replace potentially dangerous pesticides. Interestingly enough, the bees don’t even know what an integral role they are playing in all this. It’s just another routine day for them.
Click on the below interview from BNN: A recently retired Syngenta Global R&D Leader in crop protection, and Bee Vectoring Technologies Director, Claude Flueckiger, explains the potential of this small-cap company’s VectorPak:
What cannot be lost, from an investor’s standpoint, is this: Companies such as Monsanto and Bayer are being blasted by many media and activist groups, and even boycotted by some consumers, for their use of controversial pesticides. Bee Vectoring’s organic compound, distributed naturally via bees, and VectorPak, offers a potential alternative for certain crops.
Through our research, we learned that major pesticide and agriculture companies are searching for alternatives to boost and/or control crop yields while keeping consumers happy and nature in balance.
Herein lies the opportunity.
Obviously, large chemical/fertilizer companies are keen on market share. With consumers more environmentally conscious than ever, Mother Nature should be front and centre when developing products. BVT’s VectorPak offers not only a potential solution to help bees, but an organic and safe crop control option.
Bumble bees are specifically targeted by Bee Vectoring Technologies because they make roughly 1,000 pollinating trips per day, far more than their honeybee cousins, for example. Due to this fact, they are used more often in commercial growers than any other bee.
According to Beneficialbugs.org, “Bumble bees are one of natures hardest working beneficial bugs. Bumblebees drink nectar and eat pollen – nothing else. They are important Pollinators…”
Bumble bees also carry 10 times more pollen than their honey bee counterparts. This is critical as Bee Vectoring Technologies’ process involves an organic compound or inoculant which attaches to the bee’s body before it leaves the hive each time to pollinate.
The TrendHunter article, cited above, went on to state that:
“Besides cost-effectiveness and disease control, the BVT method offers meaningful organic certification of produce, greater shelf life, higher efficiency of flower protection and higher overall effectiveness, as the crops will not develop a resistance to the compound as they do to chemical pesticides.
Currently, BVT operates out of a world-class facility in Ontario, Canada, manufacturing its own bio control with a team of internationally renowned scientists.”
Below is a picture of BVT’s inoculum dispenser system that is incorporated into the lid of commercial bumble bee hives.
Integrated into the lid of the beehive is a small contained recess with a trapdoor on the top. In this way the material falls back into the hive. When this door is opened the exit to the hive is sealed off and no bees can leave as the tray is changed with refreshed inoculum and a new clean tray. This changing process occurs approximately every three days. The tray is designed to ensure the bees walk through it attracting powder to the legs. When they reach the exit they are then able to fly to forage as they would do naturally.
Unlike many other early stage products/companies, often years away from potential commercial use, BVT’s commercial laboratory & production facility is open and the company will have the “ability to manufacture up to $100 Million worth of products annually to be used within its crop protection and delivery systems,” according to its press release from October 13th.
Bee Vectoring Technologies’ story hits close to home in Ontario where its facility is located. Likely in a bid to combat the disappearance of bees, the Province of Ontario recently introduced neonicotinoids (nicotine based insecticides containing neurotoxins) regulations.
“According to the Ministry of the Environment, Ontario beekeepers have witnessed unusually high bee hive losses. In 2010-2011, winter mortality rate was 43 per cent. In 2012-2013, the mortality rate was 38 per cent. The 2013-2014 season saw the highest rate – 58 per cent. Over the past 12 years, the average rate has been 34 per cent annually.”
According to the MOE (Ministry of the Environment), beekeepers consider 15 per cent mortality rates sustainable. The 2013-2014 season hit a shocking 58 per cent mortality rate…
The MOE website states, ‘A growing body of scientific evidence shows that neonicotinoid insecticides are highly toxic to honey bees and other beneficial insects.’
“Last year, Canadian beekeepers filed a class action lawsuit against pesticide giants Bayer and Syngenta, seeking $400 million in damages. The plaintiffs claim that the firms “were negligent in their design and development of the neonicotinoid pesticides.”
Health Canada reported that, “…70 percent of dead bees collected during the corn and soybean planting periods in 2012 and 2013 had neonicotinoid residues present, while the majority of live bees did not have residues present.”
It seems reasonable to speculate that major crop-related chemical companies may be working on alternative methods so to avoid these types of lawsuits in the future.
In respect to Syngenta, a world-leader in crop protection, the company describes itself as a leading agriculture company helping to improve global food security by enabling millions of farmers to make better use of available resources. The company has developed numerous world class science and innovative crop solutions, employs 28,000 people in over 90 countries who are working to transform how crops are grown. In the company’s own words:
“We are committed to rescuing land from degradation, enhancing biodiversity and revitalizing rural communities.”
German-based Bayer AG, for another example, is one of the world’s largest multinational chemical and pharmaceutical companies. Bayer CropScience has a significant presence in Canada and is a leader in Canadian crop production.
The Problem is Not Going Away
David Schuit, owner of Saugeen Country Honey near Hannover, Ont., in the middle of 2014, stated that he had lost more than 65 million bees over the past two years.
“Since 2012, the family has lost more than 65 million bees, said Schuit. He estimates he now owns about 2,000 and attributes the monumental decline to the liberal use of neonicotinoids on nearby farms.”
Ontario BeeKeepers’ Association stated in February, 2015:
“…a compelling body of evidence has accumulated that clearly demonstrates that the wide-scale use of these persistent, water-soluble chemicals is having widespread, chronic impacts upon global biodiversity and is likely to be having major negative effects on ecosystem services such as pollination that are vital to food security and sustainable development.”
A May article by Carey Gillam from Reuters, reported:
“U.S. environmental regulators on Thursday proposed a rule that would create temporary pesticide-free zones to protect commercial honeybees…”
And that, “The restrictions are aimed at protecting bees from “pesticides that are acutely toxic” to them…”
The Reuters article went on to explain that:
“The White House has formed a task force to study the issue, and the EPA said Thursday it continues to conduct “chemical-specific risk assessments for bees” and will consider additional product-specific mitigation efforts.”
In an article from Reuters titled ‘U.S. court finds EPA was wrong to approve Dow pesticide harmful to bees‘, in September of 2015,
“A U.S. appeals court ruled on Thursday that federal regulators erred in allowing an insecticide developed by Dow AgroSciences onto the market, canceling its approval and giving environmentalists a major victory.”
“It’s a complete victory for the beekeepers we represent,” said Greg Loarie, an attorney who represents the American Honey Producers Association, the American Beekeeping Federation and other plaintiffs in the case.”
As you can see, this issue is receiving plenty of attention and action from lawmakers and media outlets because the problem and disappearance of bees is worsening.
Buyouts: enter Biologic Products
The broad sector of crop control chemicals is heating up as industry leaders search for ways to meet public demand.
Mark Anderson, a Staff Writer for the Sacramento Business Journal, wrote in September of 2014, that:
“In 2012, Bayer bought the Davis-based biologics company AgraQuest for $425 million. Most of Bayer CropScience’s biggest selling biologic products, such as fungicides Serenade and Sonata, and the insecticide Requiem, were AgraQuest products.”
“Biological controls increasingly are making inroads around the world, primarily because they don’t pose the same risks to the environment as chemical pesticides and fertilizers.”
In a separate article from Mark Anderson, he wrote that Bayer CropScience CEO Liam Condon said his company would be investing $1 billion in research-and-development labs across the U.S.
Israel’s Stockton Group, a world leader in the biopesticide business, is being acquired by China’s Hebang Group for $90 million. The Chinese firm will only retain 51% of Stockton’s shares, thus valuing the biopesticide company at nearly $180 million.
Hebang’s goal with this investment is to “support Stockton’s growth as a global leader in environmentally friendly biofungicides,” according to the Chinese firm.
Bee Vectoring Technologies: a company receiving heightened attention
While we don’t pretend to be experts on any type of insect, evidence exists to support a shift away
from questionable pesticides in a bid to save bees, a critical player in our food system.
In a mid-September article titled Revolutionizing Agriculture with Bees, Equities.com wrote that:
“By using bees to delivery [sic] natural biocontrol agents and fungal pathogens to flowering plants, Bee Vectoring Technologies could be on the cutting edge of a process that could revolutionize the way we approach agriculture by dramatically increasing the efficiency with which pesticides can be delivered.”
Also included in the Equities.com article was a text interview with Michael Collinson, President, CEO, and Chairman of Bee Vectoring Technologies (BEE:TSXV).
Collinson is the man responsible for bringing BVT from a R&D initiative to a potential commercial opportunity. With 35 years of international manufacturing, marketing and sales management experience in Canada, U.S., Asia and Europe, he was previously an executive at Teknion in business development during a period of revenue growth from $40 million to $1 billion. He was also the previous owner operator of a 350 person manufacturing company, selling internationally.
We chose to highlight 2 key questions posed by Equities.com and the responses by BVT’s CEO and Chairman.
“EQ: What should investors expect to see from Bee Vectoring Technologies over the next year?
Michael Collinson: “Bee Vectoring Technologies is the first company in the world dedicated to this process. We have two different streams of revenue that are available to us. The first being the use of the dispensing system with other companies’ inoculums.
Companies like Syngenta (SYT), Nufarm (NUFMF), Bayer CropScience (BAYRY), or Marrone Bio Innovations (MBII), for example, have a lot of bio control products that can use our distribution system. We’re looking to build partnerships over the next 12 to 14 months with these types of companies to deliver what is currently used in the marketplace in lower doses and with more efficiency.
The second revenue stream is the registration of our own bio control, BVT CR7, and that process takes about 18 to 24 months to complete.
We’re also looking to expand rapidly around the world into principal crops that we would like to focus on. So we will be moving into strawberries, tomatoes, apples, sunflowers, canola, raspberries, almonds, and some cucurbits. Those are our principal crops that we are going to focus on right now, but we are doing some trials on coffee. Principally, any pollinating plants or plants that require pollination we can deploy our system to help.”
“EQ: Do you have any additional closing comments you would like to make?
Michael Collinson: “This is probably one of the more exciting areas inside agricultural sector right now. Pesticides are a $70 or $80 billion industry and Biologicals are growing at a rate of 16% year-over-year, making it one of the fastest growing segments in the industry. This is the area where companies are paying the most attention. The cost to deliver a new product today or develop a new pesticide is in excess of $250 million.
Chemical pesticides lose their efficacy as the pathogens become immune to their properties, just like humans and the antibiotics. Biologicals don’t have the same issues.
The BVT process is a lot less expensive, more efficient, uses substantially less product, is more environmentally friendly, and definitely represents the leading edge of where agriculture is going. BVT has the ability to “stack” multiple pathogens controls into their unique patent pending systems thereby delivering controls throughout a bloom period as opposed to spraying once or twice during the same period. Naturally perfect.”
Click here to read the full article and interview from Equities.com.
Bee Vectoring Technologies’ President and CEO, Michael Collinson, was interviewed on BNN in July of this year. Click the image above to watch.
We are looking for buyout potential in every small-cap play we get involved with.
In a September, 2015 article titled Acquisition rumours are buzzing around this venture listed bee business, Jeff Lagerquist, from BNN.ca, reported on some comments:
“Michael Smedley, the executive vice president and chief investment officer at Morgan Meighen & Associates holds shares of Bee Vectoring Technologies for clients and is familiar with the business through talks with management. He hinted that a buyout could be in the works.”
Morgan Meighen & Associates has more than $1.4 billion in assets under management for private clients, institutional clients, and closed-end fund investors.
The BNN article continued with further comments by Smedley:
“Bee Vectoring has developed insecticides, or is developing until they’re really getting sold, that are non-poisonous” he said in an interview with BNN. “The products are being tested by the two largest fruit and vegetable growers in the UK.”
Jeff Lagerquist wrote in his article for BNN that,
“Fluckinger, who is also the head of global product biology for Syngenta AG’s lawn and garden division, says there is a precedent for a lucrative buyout, since most big chemical firms don’t do very much research in the field of biology and usually opt to buy up small firms.”
Click here for the full article from BNN.
Bee Vectoring Technologies: buzzing ahead
On October 13th, Bee Vectoring Technologies announced that it had opened the First-of-Its-Kind Commercial Laboratory & Production Facility for Pathogen Control Agents Deliverable by Bees.
The ‘Ontario Facility Will Be the World’s First to Commercially Produce Proprietary Organic Pathogen Control Agents Designed Specifically for Bee Propagation,‘ read the subtitle of Bee Vectoring’s press release.
The 7000-square-foot facility will house a team of internationally recognized scientists with expertise that encompass crop pest management, soil science, plant pathology and crop disease management and prediction.
Within this facility, Bee Vectoring will have the ability to manufacture up to $100 Million worth of products annually to be used within its crop protection and delivery systems.
CEO Michael Collinson said of the facility’s launch, “This is a major milestone in the commercialization of a solution that has the potential to fundamentally alter how pests and diseases are controlled in the fruit and vegetables we eat. We are fortunate to have a world-class team that has developed this solution. We now have a world class facility that will enable us to scale rapidly and take advantage of significant business development opportunities we are seeing, for a disruptive solution like BVT’s in the national and global food growing industry.”
Bee Vectoring Technologies International (BEE:TSXV)(BEVVF:OTCQB) is an innovative crop control company in the early stages of its development. This is the type of speculative investment opportunity we search for in today’s economic climate as this company attempts to combat a growing threat to our way of life.
We are biased towards Bee Vectoring Technologies because they are an advertiser client and we participated in the company’s recently announced private placement for our own investment purposes. We may also increase our share position in the company following the release of this report. Please take responsibility for practicing your own thorough and independent due diligence.
In Bee Vectoring we see a company with a stout management team, a worthy cause, and an innovative technology which could make it an attractive acquisition target.
This marks the initiation of our coverage on Bee Vectoring Technologies International (BEE:TSXV)(BEVVF:OTCQB). Its shares last traded at CAD$0.39. We will have further updates in regards to this story over the coming weeks.
All the best with your investments,
Bee Vectoring Technologies Stock Info:
TSXV symbol: BEE
OTCQB symbol: BEVVF
TSXV Stock Price: CAD$0.39
Market Cap: $17.39 million (approximate)
10-Day Avg Volume on TSXV: 137,500 (approximate)
Members of Management, Directors and Advisors
Michael Collinson, President, CEO & Chairman
35 years of international manufacturing ,marketing and sales management experience in Canada, U.S., Asia and Europe, previously an executive at Teknion in business development during the period of revenue growth from $40 million to $1 billion and ultimately becoming a public company. Previous owner operator of 350 person manufacturing company, selling internationally. Responsible for bringing BVT, from a R&D initiative to a commercial opportunity with over 4 years of experience working with the Advisory Board to realize grower demand and BVT potential.
Todd Mason, VP Research and Protocol
Over 7 years of bee vectoring experience with growers in N.A. and Europe and +30 years of international experience in N.A., Asia, Europe and the U.K., in the agricultural industry in soil management practices, agronomy, crop enhancement and disease control. Graduate of Guelph University (Agriculture and Soil Science).
Dr. Claude Flueckiger, Director
PhD in Entomology from the Swiss Federal Institute of Technology (ETH), Executive Education programs at Harvard Business School in Agribusiness, Marketing and Business Administration. Over 30 years of worldwide experience in the crop protection and seed industry as both a commercial and technical leader. Served as Global Product Management Leader for Insecticides, and as U.S. Marketing Leader for Fruits and Vegetables. Developed and lead the initial commercialization of the largest blockbuster insecticide at Syngenta.
Dr. John Sutton, Scientific Advisory Board
Worldwide expert in the epidemiology and management of diseases in crops, biological control of plant diseases, disease prediction, integrated crop protection, disease diagnosis, mycology and pioneer in clonostachys studies. Adjunct Professor in Plant Pathology at the University of Guelph since 2005.
Dr. Peter Kevan, Scientific Advisory Board
Professor Emeritus, School of Environmental Sciences at the University of Guelph since 2004, BSc honours in zoology, McGill University, 1965; PhD special merit, University of Alberta, 1970; fellow of Royal Entomological Society, fellow of Institute of Biology, fellow of Royal Society of Canada. Internationally renowned expert in bee biology and pollination biology. He is author of over 250 scientific papers. He is a pioneer in the R&D and innovation of the system and equipment for the deployment of biological control agents delivered by pollinators for the protection of crops from plant diseases and insect pests. Scientific director of the Canadian Pollination Initiative and Chair of the International Commission for plant pollinator relations and holds positions on the councils of the North American Pollinator Protection Campaign and the International Union for Biological Sciences.
Dr. Brenda Nailor, Scientific Advisory Board
Extensive experience with obtaining registration for new products in agriculture. Wide-ranging contacts in the government and senior executives in agricultural companies in North America.
Disclosure, Risks Involved and Information on Forward Looking Statements: Please read carefully before proceeding.
THIS IS NOT INVESTMENT ADVICE. All statements in this report are to be checked and verified by the reader.
This report may contain technical or other inaccuracies, omissions, or typographical errors, for which Maximus Strategic Consulting Inc., owner of PinnacleDigest.com, assumes no responsibility.
Important: Our disclosure for this report on Bee Vectoring Technologies International applies to the date this report was released to our subscribers (November 4, 2015) and posted on our website. This disclaimer will never be updated, even after we have sold all of our shares of Bee Vectoring Technologies International.
In all cases, interested parties should conduct their own investigation and analysis of Bee Vectoring Technologies International Inc., its assets and the information provided in this report.
Forward Looking Statements:
All statements in this report, other than statements of historical fact should be considered forward-looking statements. These statements relate to future events or future performance. Much of this report is comprised of statements of projection. Such statements or information involve substantial known and unknown risks and uncertainties, some of which are beyond Bee Vectoring Technologies International’s control, including general business, economic, competitive, political and social uncertainties; the willingness of third parties to sign agreements with Bee Vectoring Technologies International on terms that are acceptable to management of Bee Vectoring Technologies International; the ability of Bee Vectoring Technologies International to secure sufficient future funding to carry out all of its business plans; the continued availability of required resources (such as human resources, equipment and/or other capital resources); the ability of Bee Vectoring Technologies International to procure patent or other intellectual property protection for its technologies and to license or enforce any of its intellectual property rights. Patents in the case of Bee Vectoring Technologies International are crucial to their business and there is no guarantee that patents will be granted to them, or if granted, they may be successfully challenged.
Such forward-looking statements or information are based on a number of assumptions which may prove to be incorrect. In addition to other assumptions identified in this report, assumptions have been made regarding, among other things, operating conditions, capital and other expenditures, that Bee Vectoring Technologies International has valid intellectual property rights and is not infringing on those of any other person, and project development activities. Undue reliance should not be placed on forward-looking statements because we can give no assurance that such expectations will prove to be correct.
Risks and uncertainties respecting junior technology companies such as Bee Vectoring Technologies International are generally disclosed in the annual financial or other filing documents of those and similar companies as filed with the relevant securities commissions, and should be reviewed by any reader of this report. Investors are cautioned not to consider investing in any company without looking at said company’s regulatory filings and financial statements. Every reader of this report should review Bee Vectoring Technologies International’s regulatory filings and financial statements filed on SEDAR.
The information contained in this report are made as of the date hereof and Maximus Strategic Consulting Inc. (owner of PinnacleDigest.com) undertakes no obligation to update publicly or revise any forward-looking statements or information, whether as a result of new information or future events or otherwise.
PinnacleDigest.com is an online financial newsletter owned by Maximus Strategic Consulting Inc. We are focused on researching and marketing for resource and technology public companies. Nothing in this report should be construed as a solicitation to buy or sell any securities mentioned anywhere in this report (particularly in respect to Bee Vectoring Technologies International). This report is intended for informational and entertainment purposes only. The author of this report and its publishers bear no liability for losses and/or damages arising from the use of this report.
We Are Not Financial Advisors:
Be advised, Maximus Strategic Consulting Inc., PinnacleDigest.com and its employees are not a registered broker-dealer or financial advisors. Before investing in any securities, you should consult with your financial advisor and a registered broker-dealer.
Never, ever, make an investment based solely on what you read in an online newsletter, including Pinnacle Digest’s online newsletter, or Internet bulletin board, especially if the investment involves a small, thinly-traded company that isn’t well known.
PinnacleDigest.com’s past performance is not indicative of future results and should not be used as a reason to purchase any security mentioned in this report or on our website.
We Are Biased:
Most companies featured in our newsletter, and on our website, are paying clients of ours (including Bee Vectoring Technologies International – details in this disclaimer). In many cases, we own shares in the companies we feature. For those reasons, please be aware that we are extremely biased in regards to the companies we write about and feature in our newsletter and on our website.
Because Bee Vectoring Technologies International Inc. has paid us CAD$40,000 plus gst for our online advertising and marketing services, and we (Maximus Strategic Consulting Inc.) own shares in the company, you must recognize the inherent conflict of interest involved that may influence our perspective on Bee Vectoring Technologies International; this is why we stress that you conduct extensive due diligence as well as seek the advice of your financial advisor and a registered broker-dealer before investing in any securities mentioned in our reports.
Maximus Strategic Consulting Inc., owner of PinnacleDigest.com, its officers, directors, employees, and consultants shall not be liable for any damages, losses, or costs of any kind or type arising out of or in any way connected with the use of its reports, products or services, including this report. Maximus Strategic Consulting Inc, owner of PinnacleDigest.com, its employees, consultants and affiliates are not responsible for any information provided by any of the companies mentioned in our reports or third party writers. You should independently investigate and fully understand all risks before investing.
We want to remind you again that PinnacleDigest.com is often paid editorial fees for its writing and the dissemination of material. The clients (including Bee Vectoring Technologies International) represented by PinnacleDigest.com are typically early-stage companies that pose a much higher risk to investors than established companies. When investing in speculative stocks such as Bee Vectoring Technologies International Inc. it is possible to lose your entire investment over time or even quickly.
Set forth below is our disclosure of compensation received from Bee Vectoring Technologies International and details of our stock ownership in the company as of November 4, 2015:
Maximus Strategic Consulting Inc., owner of PinnacleDigest.com, has been paid CAD$40,000 plus gst to provide online advertisement coverage for Bee Vectoring Technologies International Inc. for a pre-paid nine month online marketing agreement. The company (Bee Vectoring Technologies International Inc.) has paid for this coverage. The coverage includes, but is not limited to, the creation and distribution of reports authored by PinnacleDigest.com about Bee Vectoring Technologies International Inc. (reports such as this one), as well as display advertisements and news distribution about the company on our website and in our newsletter. This is our first report on Bee Vectoring Technologies International Inc. We (Maximus Strategic Consulting Inc., owner of PinnacleDigest.com) subscribed to Bee Vectoring Technologies International’s private placement. In that private placement, we purchased 92,500 common shares of Bee Vectoring Technologies International Inc. at a price of $0.27 per share. The shares purchased in the private placement are subject to a four-month hold period expiring on February 23, 2016. We (Maximus Strategic Consulting Inc.) may buy more shares of Bee Vectoring Technologies International Inc. following the release of this report. We (Maximus Strategic Consulting Inc.) intend to sell every share we own, as well as any shares we may purchase in the future, of Bee Vectoring Technologies International Inc. for our own profit. All shares we (Maximus Strategic Consulting Inc.) currently own or purchase in the future of Bee Vectoring Technologies International Inc. will be sold without notice to our subscribers. Please recognize that we benefit from price and trading volume increases in Bee Vectoring Technologies International Inc. Please recognize that we are extremely biased when it comes to Bee Vectoring Technologies International Inc.
Maximus Strategic Consulting Inc. and PinnacleDigest.com (including its employees and consultants) are not chartered business valuators; the methods used by business valuators often cannot justify any trading price for most junior stock exchange listed companies. Bee Vectoring Technologies International Inc. is considered to be a junior stock exchange listed company.
All information in this report regarding Bee Vectoring Technologies International’s market cap, stock price and trading information was sourced from Quotemedia or Bloomberg. There are no guarantees that these figures are accurate or complete.
Any decision to purchase or sell as a result of the opinions expressed in this report OR ON PinnacleDigest.com will be the full responsibility of the person authorizing such transaction, and should only be made after such person has consulted a registered financial advisor and conducted thorough due diligence. Information in this report has been obtained from sources considered to be reliable, but we do not guarantee that it is accurate or complete. Our views and opinions regarding the companies we feature on PinnacleDigest.com and in this report are our own views and are based on information that we have received, which we assumed to be reliable. We do not guarantee that any of the companies mentioned in this report (specifically Bee Vectoring Technologies International Inc.) or on PinnacleDigest.com will perform as we expect, and any comparisons we have made to other companies may not be valid or come into effect.
To get an up to date account on any changes to our disclosure for Bee Vectoring Technologies International (which will change over time) view our full disclosure at the url listed here:
Maximus Strategic Consulting Inc, owner of PinnacleDigest.com, does not undertake any obligation to publicly update or revise any statements made in this report. The information in this report is subject to change without notice.
Under no circumstances is this report allowed to be reposted, copied or redistributed without the express consent of Pinnacle Digest.
Learn how to protect yourself and become a more informed investor at www.investright.org.